说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 急性非淋巴白血病细胞
1)  Acute non-lymphocytic leukemia cell lines
急性非淋巴白血病细胞
2)  acute non-lymphocytic leukemia
急性非淋巴细胞白血病
1.
Clinic analysis of childhood acute non-lymphocytic leukemia;
儿童急性非淋巴细胞白血病临床分析
2.
The aim of this study was to evaluate the safety and efficacy of allogeneic hematopoietic peripheral blood stem cell transplantation (allo-PBHSCT) for post-operative therapy of acute non-lymphocytic leukemia (ANLL) patient complicated with renal cell carcinoma (RCC).
本研究探索异基因造血干细胞移植治疗急性非淋巴细胞白血病合并肾细胞癌切除术后患者的有效性与安全性。
3.
To explore the expression of livin gene in acute non-lymphocytic leukemia(ANLL)cells and its clinical significance,the mRNA level of livin gene in 46 ANLL adult patients were measured by using reverse transcription polymerase chain reaction(RT-PCR).
为了探讨急性非淋巴细胞白血病(ANLL)原代细胞livin基因表达及临床意义,采用逆转录-聚合酶链反应(RT-PCR)检测46例急性非淋巴细胞白血病患者livin基因mRNA表达水平,以10名健康人为正常对照,以HL-60细胞株为阳性对照。
3)  Acute nonlymphoblastic leukemia
急性非淋巴细胞白血病
1.
From October 1995 to August 1988,58 untreated patients with acute nonlymphoblastic leukemia(ANLL) ranging in age from 14 to 65 years were randomized to receive MA( Mitoxantrone 10mg/day iv for 3 days, cytosine arabinoside 150mg/day iv for 7 days or DA(daunorubicin 40 mg/m\+2/day iv for 3days , cytosine arabinoside 150 mg/day iv for 7 days), 16 of 28 caces (57.
本文报告MA和DA方案治疗急性非淋巴细胞白血病 (ANLL) 5 8例 ,其中 2 8例用MA方案 ,CR16例 (5 7 1% ) ;30例用DA方案 ,CR18例 (6 0 % ) ,两种方案CR率相似 (P >0 0 5 )。
4)  acute non lymphocytic leukemia
急性非淋巴细胞白血病
1.
This study was designed to explore the influence of STI571, a tyrosine kinase inhibitor, on the expression of c kit in the bone marrow cells from patients with acute non lymphocytic leukemia (ANLL).
为了探讨STI5 71体外对急性非淋巴细胞白血病患者骨髓细胞c kit表达的影响 ,采用逆转录 聚合酶链反应及流式细胞术分别测定不同浓度STI5 71处理前后骨髓细胞c kitmRNA及CD117的表达。
2.
Methods: The bone marrow cells of 36 patients with acute non lymphocytic leukemia (ANLL), 26 patients with acute lymphocytic leukemia (ALL) and 23 cases of normal control were detected for mutations in p53 and MGMT gene using polymerase chain reaction single strand conformation polymorphism ( PCR SSCP ).
方法 :应用聚合酶链反应 单链构象多态性 (PCR SSCP )技术 ,对 36例急性非淋巴细胞白血病 (AN LL) ,2 6例急性淋巴细胞白血病 (ALL)和 2 3例健康对照组骨髓细胞的 p5 3和MGMT基因突变进行了分析。
5)  acute non lymphoid leukemia
非淋巴细胞急性白血病
6)  acute nonlymphocytic leukemia
急性非淋巴细胞白血病
1.
Cytogenetic analysis on 1058 cases of acute nonlymphocytic leukemia;
1058例急性非淋巴细胞白血病的细胞遗传学分析
2.
The acute nonlymphocytic leukemia(ANLL) was the highest(49.
急性非淋巴细胞白血病(ANLL)756例占49。
3.
Objective To compare the efficacy and adverse reaction of chemotherapy in DA protocol alone or combined with Shenqifuzheng injection(SFI) for treatment of acute nonlymphocytic leukemia.
目的比较参芪扶正注射液联合DA化疗方案或单纯DA方案治疗急性非淋巴细胞白血病(ANLL)的疗效及不良反应。
补充资料:慢性淋巴细胞性白血病


慢性淋巴细胞性白血病


简称"慢淋"。系免疫无能的小淋巴细胞恶性增殖性疾病。起病比慢粒更缓慢,临床表现更为多样化。早期常无症状或仅有轻度不适,可在体检或血细胞检验时偶然发现。首发症状为淋巴结肿大,其次为乏力、消瘦等。全身症状如发热、盗汗、瘙痒等多为疾病进展的征象。待疾病晚期贫血及出血同时出现。本病预后相对良好,患者又多为老年,所以不必由于淋巴细胞增多而急于治疗。症状明显者,一般采用化疗和放射治疗等。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条